Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma

Autologous stem cell transplantation (ASCT) is considered the standard therapy for younger patients with newly diagnosed symptomatic multiple myeloma (MM). The introduction into clinical practice of novel agents, such as the proteasome inhibitor bortezomib and the immunomodulatory derivatives (IMiDs...

Descripción completa

Detalles Bibliográficos
Autores principales: Ria, Roberto, Reale, Antonia, Solimando, Antonio Giovanni, Mangialardi, Giuseppe, Moschetta, Michele, Gelao, Lucia, Iodice, Giuseppe, Vacca, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369512/
https://www.ncbi.nlm.nih.gov/pubmed/22701493
http://dx.doi.org/10.1155/2012/607260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369512/
https://www.ncbi.nlm.nih.gov/pubmed/22701493
http://dx.doi.org/10.1155/2012/607260

Ejemplares similares